跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Velsta - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Velsta
Approved
STANDARD
Velsta
Bafna Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0fb8e2565088f47b
Company
Bafna Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
0fb8e2565088f47b
Drug Approval Philippines Name
Velsta
Product Name
Velsta
Registration Number
DRP-12701
Brand Name
Velsta
Generic Name
Montelukast (as Sodium) + Levocetirizine hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg/5 mg
Manufacturer
Bafna Pharmaceuticals Limited
Importer
MedEthix, Inc.
Distributor
Multicare Pharmaceuticals Phils., Inc
Issuance Date
28 September 2022
Expiry Date
03 July 2027
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0fb8e2565088f47b
Type
Standard
Back to Philippines FDA Approvals